RCS - Tristel PLC - Journal of Ultrasound in Medicine & Biology <Origin Href="QuoteRef">TSTL.L</Origin>
RNS Number : 8492XTristel PLC27 February 2017Tristel plc
("Tristel" or the "Company")
Tristel's Wipes and foam disinfectants included in Journal of Ultrasound in Medicine & Biology
Tristel plc (AIM: TSTL), the manufacturer of infection prevention, contamination control and hygiene products, announces that the World Federation for Ultrasound in Medicine & Biology has provided guidance to healthcare organisations worldwide regarding the safe and effective cleaning and disinfection of transvaginal and transrectal ultrasound probes.
The Technical Note identifies various high-level disinfectants that are recommended by ultrasound manufacturers and comments that Tristel's chlorine dioxide is being used extensively in the United Kingdom and Australia. Both the Trio Wipes System and the Duo Foam product are named. Tristel is pursuing a regulatory approval from the United States Food and Drug Administration (FDA) for the Duo Foam.
The Technical Note concludes that disinfection of the ultrasound probe is mandatory. However, in many countries probes are not disinfected even though the probe is used in gynaecological procedures where there is a proven high risk of contamination of the instrument by pathogens such as human immunodeficiency virus (HIV) and human papillomavirus (HPV). HPV is proven to be the main causal agent for cervical cancer. In addition, specific concerns include gonorrhoea and syphilis for vaginal probes and Clostridium difficile for transrectal probes.
The study has been published as a Technical Note in the Journal of Ultrasound in Medicine & Biology
[Abramovich, J. S., Evans, D. H., Fowlkes, J. B., Marsal, K., terHaar, G. 'Guidelines for Cleaning Transvaginal Ultrasound Transducers Between Patients', (2017). DOI: 10.1016/j.ultrasmedbio.2017.01.002].
Paul Swinney, CEO of Tristel plc, comments: "Ultrasound scans in women's health are one of the world's most commonplace diagnostic procedures. It is astounding that so many of these procedures are undertaken without the instrument being properly disinfected between patients. Our Trio and Duo products are two of very few disinfectant products that are designed specifically for women's health. Guidance such as this from the World Federation can only encourage patients to demand that the instrument being used on them is safe because it has been properly disinfected."
For further information please contact:
Tristel plc
Paul Swinney, Chief Executive
Tel: 01638 721 500
Liz Dixon, Finance Director
finnCap
Geoff Nash / Giles Rolls, Corporate Finance
Tel: 020 7220 0500
Alice Lane, Corporate Broking
Walbrook PR Ltd
Tel: 020 7933 8780 or tristel@walbrookpr.com
Paul McManus
Mob: 07980 541 893
Lianne Cawthorne
Mob: 07584 391 303
This information is provided by RNSThe company news service from the London Stock ExchangeENDNRALLFLDFVISFID
Recent news on Tristel
See all newsREG - AIM - AIM Notice - 19/04/2024
AnnouncementREG - Tristel PLC - Director/PDMR Shareholding
AnnouncementREG - Tristel PLC - Exercise of Share Options and Total Voting Rights
AnnouncementREG - Tristel PLC - Exercise of Share Options and Total Voting Rights
AnnouncementREG - AIM - AIM Notice - 28/02/2024
Announcement